These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 29860716)
21. Pheochromocytoma associated with adrenocortical tumor in the same gland. Two case reports and literature review. Cotesta D; Petramala L; Serra V; Giustini S; Divona L; Calvieri S; De Toma G; Ciardi A; Corsi A; Massa R; Reale MG; Letizia C Minerva Endocrinol; 2006 Jun; 31(2):183-9. PubMed ID: 16682942 [TBL] [Abstract][Full Text] [Related]
22. I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. Grassi I; Nanni C; Vicennati V; Castellucci P; Allegri V; Montini GC; Pagotto U; di Dalmazi G; Pasquali R; Fanti S Clin Nucl Med; 2011 Feb; 36(2):124-6. PubMed ID: 21220975 [TBL] [Abstract][Full Text] [Related]
23. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. De Graaf JS; Dullaart RP; Kok T; Piers DA; Zwierstra RP Eur J Surg; 2000 Apr; 166(4):289-92. PubMed ID: 10817323 [TBL] [Abstract][Full Text] [Related]
24. Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma. Meyer-Rochow GY; Smith JM; Richardson AL; Marsh DJ; Sidhu SB; Robinson BG; Benn DE J Surg Res; 2009 Nov; 157(1):55-62. PubMed ID: 19215943 [TBL] [Abstract][Full Text] [Related]
25. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma. Greenblatt DY; Shenker Y; Chen H Ann Surg Oncol; 2008 Mar; 15(3):900-5. PubMed ID: 18193324 [TBL] [Abstract][Full Text] [Related]
26. Genetic status determines Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398 [TBL] [Abstract][Full Text] [Related]
27. Pheochromocytoma in multiple endocrine neoplasia type 2A: positive 123I MIBG with negative CT and equivocal 131I MIBG imaging. Ishii S; Shishido F; Miyajima M; Sakuma K; Kikuchi K Clin Nucl Med; 2012 Jun; 37(6):596-8. PubMed ID: 22614196 [TBL] [Abstract][Full Text] [Related]
28. [Bilateral adrenal pheochromocytoma. A case report]. Benchekroun A; Lachkar A; Soumana A; Farih MH; Belahnech Z; Marzouk M; Faik M Ann Urol (Paris); 1998; 32(5):274-8. PubMed ID: 9827197 [TBL] [Abstract][Full Text] [Related]
30. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma. Lugat A; Drui D; Mirallié E; Kraeber-Bodéré F; Ansquer C Clin Nucl Med; 2019 Sep; 44(9):738-740. PubMed ID: 31306205 [TBL] [Abstract][Full Text] [Related]
31. 123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma. Cuenca-Cuenca JI; Marín-Oyaga VA; Borrego-Dorado I; Navarro-González E; Martos-Martínez JM; Vázquez-Albertino R Rev Esp Med Nucl Imagen Mol; 2013; 32(4):263-5. PubMed ID: 23434017 [TBL] [Abstract][Full Text] [Related]
32. [Severe arterial hypertension and pheochromocytoma in childhood. Case report and review of the literature]. Laporte R; Godart F; Brevière GM; Vaksmann G; Francart C; Rey C Arch Mal Coeur Vaiss; 2000 May; 93(5):627-30. PubMed ID: 10858862 [TBL] [Abstract][Full Text] [Related]
33. Detecting pheochromocytoma: defining the most sensitive test. Guller U; Turek J; Eubanks S; Delong ER; Oertli D; Feldman JM Ann Surg; 2006 Jan; 243(1):102-7. PubMed ID: 16371743 [TBL] [Abstract][Full Text] [Related]
34. A diagnostic dilemma in diagnosing and managing an incidental phaeochromocytoma. Tahrani AA; Macleod AF Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):204-7. PubMed ID: 16705554 [TBL] [Abstract][Full Text] [Related]
35. [Bilateral pheochromocytomas with von Hippel-Lindau disease: a case report]. Masunaga K; Inadome A; Sugiyama Y; Maeda Y; Satoji Y; Takahashi W; Yoshida M; Ueda S; Ikeda K; Takano Y; Yatsuda J Nihon Hinyokika Gakkai Zasshi; 2007 Nov; 98(7):843-7. PubMed ID: 18062217 [TBL] [Abstract][Full Text] [Related]
36. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma. Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579 [TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography with 18F-fluorodeoxyglucose is a useful tool for the diagnosis of pheochromocytomas without distant metastasis, where malignancy is suspected on the basis of histopathologic analysis. Kikuchi F; Imachi H; Murao K; Ohyama T; Miyai Y; Kushida Y; Haba R; Kakehi Y; Ishida T Am J Med Sci; 2010 Aug; 340(2):160-3. PubMed ID: 20693835 [TBL] [Abstract][Full Text] [Related]
38. [Personal experience in diagnosis and localization of pheochromocytoma]. Andjelković Z; Tavcar I Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992 [TBL] [Abstract][Full Text] [Related]
39. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma. Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850 [TBL] [Abstract][Full Text] [Related]